FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311752808> ?p ?o ?g. }

• W4311752808 abstract "Abstract Background Staphylococcus aureus urinary tract infection (UTI) is uncommon. Staphylococcus aureus bacteriuria (SABU) can occur in patients with urinary tract instrumentation, urinary calculi, or S. aureus bacteremia (SAB) and is associated with development of invasive diseases and death. Thus, SABU is often treated with a prolonged course of antimicrobial therapy similar to SAB. However, little is known about the significance of SABU in patients without SAB and recent urinary tract instrumentation. Methods We conducted a retrospective study of patients with SABU in the Veterans Affairs (VA) system nation-wide from 2017 to 2019. Patients with concomitant SAB, recent history of urinary tract instrumentation, or overt urologic abnormalities were excluded. The primary outcome was development of invasive S. aureus infections or death within 12 months. The secondary outcome was recurrent SABU within 12 months. Results 133 patients met the inclusion criteria. 102 patients (76%) received antimicrobial treatment for SABU. The duration of treatment ranged from 3-30 (mean = 8.5) days. Compared with the non-treated group, patients treated with antimicrobials had significantly more urinary tract symptoms (p = 0.0001), microscopic pyuria (p = 0.002), and hematuria (p = 0.035). Of those treated, 11 (7.3%) died within 12 months of SABU compared to 4 patients (13%) who did not receive treatment (p = 0.749). Three percent of patients from both groups (n = 3 vs 1) developed invasive S. aureus infections within 12 months (p = 1.00). 16% of patients in the treatment group (n = 17) and non-treatment group (n = 5) were found to have recurrent SABU within 12 months (p = 1.00). Conclusion Patients without recent urinary tract instrumentation, overt urologic abnormalities, and SAB who were treated for SABU did not have significant differences in death, invasive diseases, or recurrent SABU at 12 months compared to those who did not receive treatment. Untreated patients did not appear to have frequent complications; however, our numbers were small and our analysis did not take confounding into account. Further analysis into SABU treatment may be warranted. Disclosures All Authors: No reported disclosures." @default.
• W4311752808 created "2022-12-28" @default.
• W4311752808 creator A5029814123 @default.
• W4311752808 creator A5043213270 @default.
• W4311752808 creator A5047128905 @default.
• W4311752808 date "2022-12-01" @default.
• W4311752808 modified "2023-10-18" @default.
• W4311752808 title "2234. Clinical Significance of <i>Staphylococcus aureus</i> Bacteriuria without Bacteremia" @default.
• W4311752808 doi "https://doi.org/10.1093/ofid/ofac492.1852" @default.
• W4311752808 hasPublicationYear "2022" @default.
• W4311752808 type Work @default.
• W4311752808 citedByCount "0" @default.
• W4311752808 crossrefType "journal-article" @default.
• W4311752808 hasAuthorship W4311752808A5029814123 @default.
• W4311752808 hasAuthorship W4311752808A5043213270 @default.
• W4311752808 hasAuthorship W4311752808A5047128905 @default.
• W4311752808 hasBestOaLocation W43117528081 @default.
• W4311752808 hasConcept C126322002 @default.
• W4311752808 hasConcept C141071460 @default.
• W4311752808 hasConcept C2775886723 @default.
• W4311752808 hasConcept C2776216170 @default.
• W4311752808 hasConcept C2779384505 @default.
• W4311752808 hasConcept C2779443120 @default.
• W4311752808 hasConcept C2779489039 @default.
• W4311752808 hasConcept C4937899 @default.
• W4311752808 hasConcept C501593827 @default.
• W4311752808 hasConcept C523546767 @default.
• W4311752808 hasConcept C54355233 @default.
• W4311752808 hasConcept C71924100 @default.
• W4311752808 hasConcept C77411442 @default.
• W4311752808 hasConcept C86803240 @default.
• W4311752808 hasConcept C89423630 @default.
• W4311752808 hasConceptScore W4311752808C126322002 @default.
• W4311752808 hasConceptScore W4311752808C141071460 @default.
• W4311752808 hasConceptScore W4311752808C2775886723 @default.
• W4311752808 hasConceptScore W4311752808C2776216170 @default.
• W4311752808 hasConceptScore W4311752808C2779384505 @default.
• W4311752808 hasConceptScore W4311752808C2779443120 @default.
• W4311752808 hasConceptScore W4311752808C2779489039 @default.
• W4311752808 hasConceptScore W4311752808C4937899 @default.
• W4311752808 hasConceptScore W4311752808C501593827 @default.
• W4311752808 hasConceptScore W4311752808C523546767 @default.
• W4311752808 hasConceptScore W4311752808C54355233 @default.
• W4311752808 hasConceptScore W4311752808C71924100 @default.
• W4311752808 hasConceptScore W4311752808C77411442 @default.
• W4311752808 hasConceptScore W4311752808C86803240 @default.
• W4311752808 hasConceptScore W4311752808C89423630 @default.
• W4311752808 hasIssue "Supplement_2" @default.
• W4311752808 hasLocation W43117528081 @default.
• W4311752808 hasOpenAccess W4311752808 @default.
• W4311752808 hasPrimaryLocation W43117528081 @default.
• W4311752808 hasRelatedWork W1969858835 @default.
• W4311752808 hasRelatedWork W2008490791 @default.
• W4311752808 hasRelatedWork W2041548091 @default.
• W4311752808 hasRelatedWork W2098429910 @default.
• W4311752808 hasRelatedWork W2396427211 @default.
• W4311752808 hasRelatedWork W2467213941 @default.
• W4311752808 hasRelatedWork W2731408754 @default.
• W4311752808 hasRelatedWork W2741672778 @default.
• W4311752808 hasRelatedWork W4205214444 @default.
• W4311752808 hasRelatedWork W4312457352 @default.
• W4311752808 hasVolume "9" @default.
• W4311752808 isParatext "false" @default.
• W4311752808 isRetracted "false" @default.
• W4311752808 workType "article" @default.